ATE446085T1 - Partikel zur verwendung in einer pharmazeutischen zusammensetzung - Google Patents
Partikel zur verwendung in einer pharmazeutischen zusammensetzungInfo
- Publication number
- ATE446085T1 ATE446085T1 AT01998327T AT01998327T ATE446085T1 AT E446085 T1 ATE446085 T1 AT E446085T1 AT 01998327 T AT01998327 T AT 01998327T AT 01998327 T AT01998327 T AT 01998327T AT E446085 T1 ATE446085 T1 AT E446085T1
- Authority
- AT
- Austria
- Prior art keywords
- particles
- pharmaceutical composition
- dry powder
- additive material
- active particles
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0029261A GB0029261D0 (en) | 2000-11-30 | 2000-11-30 | Method of making particles for use in a pharmaceutical composition |
GB0030946A GB0030946D0 (en) | 2000-12-19 | 2000-12-19 | Method of making particles for use in a pharmaceutical composition |
GB0124009A GB0124009D0 (en) | 2001-10-05 | 2001-10-05 | Particles for use in a pharmaceutical composition |
PCT/GB2001/005305 WO2002043700A2 (en) | 2000-11-30 | 2001-11-30 | Particles for use in a pharmaceutical composition |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE446085T1 true ATE446085T1 (de) | 2009-11-15 |
Family
ID=27255994
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01998327T ATE446085T1 (de) | 2000-11-30 | 2001-11-30 | Partikel zur verwendung in einer pharmazeutischen zusammensetzung |
Country Status (8)
Country | Link |
---|---|
US (3) | US8580306B2 (de) |
EP (3) | EP1337239B2 (de) |
AT (1) | ATE446085T1 (de) |
AU (1) | AU2002220857A1 (de) |
DE (1) | DE60140268D1 (de) |
ES (2) | ES2689704T3 (de) |
PT (1) | PT1337239E (de) |
WO (1) | WO2002043700A2 (de) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9515182D0 (en) * | 1995-07-24 | 1995-09-20 | Co Ordinated Drug Dev | Improvements in and relating to powders for use in dry powder inhalers |
GB0009469D0 (en) * | 2000-04-17 | 2000-06-07 | Vectura Ltd | Improvements in or relating to formalities for use in inhaler devices |
WO2002000197A1 (en) | 2000-06-27 | 2002-01-03 | Vectura Limited | Method of making particles for use in a pharmaceutical composition |
EP2283818B1 (de) | 2000-11-30 | 2017-08-02 | Vectura Limited | Herstellungsverfahren für Partikel zur Verwendung in einer Arrzneizusammensetzung |
NZ526059A (en) † | 2000-11-30 | 2005-05-27 | Vectura Ltd | Method of making composite active particles in the presence of an additive material for use in a pharmaceutical composition |
WO2002043700A2 (en) * | 2000-11-30 | 2002-06-06 | Vectura Limited | Particles for use in a pharmaceutical composition |
US20040121003A1 (en) * | 2002-12-19 | 2004-06-24 | Acusphere, Inc. | Methods for making pharmaceutical formulations comprising deagglomerated microparticles |
US20120321717A1 (en) * | 2003-04-14 | 2012-12-20 | Vectura Ltd. | Devices and pharmaceutical compositions for enhancing dosing efficiency |
US20060147389A1 (en) * | 2004-04-14 | 2006-07-06 | Vectura Ltd. | Devices and pharmaceutical compositions for enhancing dosing efficiency |
GB0327723D0 (en) * | 2003-09-15 | 2003-12-31 | Vectura Ltd | Pharmaceutical compositions |
GB0321607D0 (en) * | 2003-09-15 | 2003-10-15 | Vectura Ltd | Manufacture of pharmaceutical compositions |
GB0425758D0 (en) * | 2004-11-23 | 2004-12-22 | Vectura Ltd | Preparation of pharmaceutical compositions |
GB0426301D0 (en) * | 2004-11-30 | 2004-12-29 | Vectura Ltd | Pharmaceutical formulations |
GB0525254D0 (en) | 2005-12-12 | 2006-01-18 | Jagotec Ag | Powder compositions for inhalation |
CA2631492A1 (en) * | 2005-12-15 | 2007-06-21 | Acusphere, Inc. | Processes for making particle-based pharmaceutical formulations for oral administration |
GB0712316D0 (en) * | 2007-06-26 | 2007-08-01 | Entripneur Ltd | A novel powder and its method of manufacture |
WO2009142852A2 (en) | 2008-05-22 | 2009-11-26 | 3M Innovative Properties Company | Process for manufacturing flowable powder drug compositions |
WO2009158300A1 (en) | 2008-06-26 | 2009-12-30 | 3M Innovative Properties Company | Dry powder pharmaceutical compositions for pulmonary administration, and methods of manufacturing thereof |
WO2010002613A2 (en) | 2008-07-02 | 2010-01-07 | 3M Innovative Properties Company | Method of making a dry powder pharmaceutical composition |
DK2400950T3 (da) | 2009-02-26 | 2019-07-29 | Glaxo Group Ltd | Farmaceutiske formuleringer omfattende 4-{(1 r)-2-[(6-{2-[(2,6-dichlorbenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol |
GB0921075D0 (en) | 2009-12-01 | 2010-01-13 | Glaxo Group Ltd | Novel combination of the therapeutic agents |
KR101895759B1 (ko) * | 2009-12-14 | 2018-09-05 | 키에시 파르마슈티시 엣스. 피. 에이. | 흡입용 항생제 미립자 |
KR20140147891A (ko) | 2012-04-13 | 2014-12-30 | 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 | 응집체 입자 |
JP5087182B1 (ja) * | 2012-06-13 | 2012-11-28 | クリニプロ株式会社 | 吸入用パウダーの製造方法 |
WO2016064907A1 (en) * | 2014-10-20 | 2016-04-28 | Rx Analytic, Inc. | A drug-containing micro particle |
DK3212212T3 (da) | 2014-10-31 | 2020-12-21 | Univ Monash | Pulverformulering |
WO2017035408A1 (en) | 2015-08-26 | 2017-03-02 | Achillion Pharmaceuticals, Inc. | Compounds for treatment of immune and inflammatory disorders |
AR106018A1 (es) | 2015-08-26 | 2017-12-06 | Achillion Pharmaceuticals Inc | Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos |
WO2018005552A1 (en) | 2016-06-27 | 2018-01-04 | Achillion Pharmaceuticals, Inc. | Quinazoline and indole compounds to treat medical disorders |
KR102632860B1 (ko) | 2017-03-01 | 2024-02-02 | 아칠리온 파르마세우티칼스 인코포레이티드 | 의학적 장애의 치료를 위한 아릴, 헤테로아릴, 및 헤테로사이클릭 약학적 화합물 |
BR112020006609A2 (pt) * | 2017-10-02 | 2020-10-06 | Board Of Regents, The University Of Texas System | composição inalável de clofazimina e seus métodos de uso |
WO2019191112A1 (en) | 2018-03-26 | 2019-10-03 | C4 Therapeutics, Inc. | Cereblon binders for the degradation of ikaros |
US20230022157A1 (en) | 2018-08-20 | 2023-01-26 | Achillion Pharmaceuticals, Inc. | Pharmaceutical compounds for the treatment of complement factor d medical disorders |
WO2020081723A1 (en) | 2018-10-16 | 2020-04-23 | Georgia State University Research Foundation, Inc. | Carbon monoxide prodrugs for the treatment of medical disorders |
Family Cites Families (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB124009A (en) | 1918-01-12 | 1919-03-12 | Walter Edward Kimber | Improvements in and connected with the Manufacture of Tools for Turning, Planing, Boring and similar purposes. |
GB1381872A (en) | 1971-06-22 | 1975-01-29 | Fisons Ltd | Pharmaceutical compositions for inhalation |
US5192528A (en) | 1985-05-22 | 1993-03-09 | Liposome Technology, Inc. | Corticosteroid inhalation treatment method |
IT1204826B (it) | 1986-03-04 | 1989-03-10 | Chiesi Farma Spa | Composizioni farmaceutiche per inalazione |
US5320906A (en) * | 1986-12-15 | 1994-06-14 | Vestar, Inc. | Delivery vehicles with amphiphile-associated active ingredient |
ATE77947T1 (de) * | 1987-04-09 | 1992-07-15 | Fisons Plc | Pentamidin enthaltende pharmazeutische zusammensetzungen. |
JP2668880B2 (ja) | 1987-06-23 | 1997-10-27 | 日本油脂株式会社 | 被覆アミノ酸類の製造方法 |
US5190764A (en) | 1988-03-03 | 1993-03-02 | Hokko Chemical Industry Co., Ltd. | Agent for imparting a sustained release property to a pesticide, a pesticide having a sustained release property and a process for the production thereof |
US5223244A (en) | 1988-06-20 | 1993-06-29 | Shiseido Company, Ltd. | Aerosol composition |
US4906476A (en) | 1988-12-14 | 1990-03-06 | Liposome Technology, Inc. | Novel liposome composition for sustained release of steroidal drugs in lungs |
EP0470154B1 (de) | 1989-04-28 | 1996-06-05 | Riker Laboratories, Inc. | Inhalationsvorrichtung für trockenpulver |
US5188837A (en) | 1989-11-13 | 1993-02-23 | Nova Pharmaceutical Corporation | Lipsopheres for controlled delivery of substances |
GB9024366D0 (en) | 1990-11-09 | 1991-01-02 | Glaxo Group Ltd | Medicaments |
US5145684A (en) | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
US5413804A (en) * | 1991-04-23 | 1995-05-09 | Cacique, Inc. | Process for making whey-derived fat substitute product and products thereof |
GB2269992A (en) * | 1992-08-14 | 1994-03-02 | Rh Ne Poulenc Rorer Limited | Powder inhalation formulations |
JPH0696517A (ja) | 1992-09-11 | 1994-04-08 | Matsushita Electric Ind Co Ltd | 磁気ディスク装置 |
NZ248813A (en) * | 1992-11-25 | 1995-06-27 | Eastman Kodak Co | Polymeric grinding media used in grinding pharmaceutical substances |
TW402506B (en) * | 1993-06-24 | 2000-08-21 | Astra Ab | Therapeutic preparation for inhalation |
US5506203C1 (en) | 1993-06-24 | 2001-02-06 | Astra Ab | Systemic administration of a therapeutic preparation |
DE4323636A1 (de) | 1993-07-15 | 1995-01-19 | Hoechst Ag | Arzneistoffzubereitungen aus umhüllten, schwerstwasserlöslichen Arzneistoffen für Inhalationsarzneiformen und Verfahren zu ihrer Herstellung |
US5744155A (en) * | 1993-08-13 | 1998-04-28 | Friedman; Doron | Bioadhesive emulsion preparations for enhanced drug delivery |
GB9322014D0 (en) | 1993-10-26 | 1993-12-15 | Co Ordinated Drug Dev | Improvements in and relating to carrier particles for use in dry powder inhalers |
CZ295827B6 (cs) * | 1994-03-07 | 2005-11-16 | Nektar Therapeutics | Způsob aerosolizace dávky inzulinu, inzulinový přípravek a jeho použití |
US5711934A (en) * | 1994-04-11 | 1998-01-27 | Abbott Laboratories | Process for the continuous milling of aerosol pharmaceutical formulations in aerosol propellants |
US6103271A (en) | 1994-12-02 | 2000-08-15 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Microencapsulation and electrostatic processing method |
PL320856A1 (en) | 1994-12-22 | 1997-11-10 | Astra Ab | Aerosol drug preparations |
US6524557B1 (en) | 1994-12-22 | 2003-02-25 | Astrazeneca Ab | Aerosol formulations of peptides and proteins |
GB9501841D0 (en) | 1995-01-31 | 1995-03-22 | Co Ordinated Drug Dev | Improvements in and relating to carrier particles for use in dry powder inhalers |
US5612053A (en) | 1995-04-07 | 1997-03-18 | Edward Mendell Co., Inc. | Controlled release insufflation carrier for medicaments |
US5635160A (en) | 1995-06-07 | 1997-06-03 | The University Of North Carolina At Chapel Hill | Dinucleotides useful for the treatment of cystic fibrosis and for hydrating mucus secretions |
US5931809A (en) | 1995-07-14 | 1999-08-03 | Depotech Corporation | Epidural administration of therapeutic compounds with sustained rate of release |
GB9515182D0 (en) | 1995-07-24 | 1995-09-20 | Co Ordinated Drug Dev | Improvements in and relating to powders for use in dry powder inhalers |
US5985309A (en) * | 1996-05-24 | 1999-11-16 | Massachusetts Institute Of Technology | Preparation of particles for inhalation |
US5874064A (en) * | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
DE19645359A1 (de) * | 1996-11-04 | 1998-05-07 | Bayer Ag | Verfahren zur Herstellung von Alkylhalogensilanen |
ES2189269T3 (es) * | 1997-12-03 | 2003-07-01 | Britannia Pharmaceuticals Ltd | Mejoras en medicamentos para el tratamiento del asma. |
US6178414B1 (en) | 1997-12-16 | 2001-01-23 | Nortel Networks Limited | Method and apparatus for updating and searching an ordered list of values stored within a memory resource |
US6086376A (en) | 1998-01-30 | 2000-07-11 | Rtp Pharma Inc. | Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant |
US7521068B2 (en) * | 1998-11-12 | 2009-04-21 | Elan Pharma International Ltd. | Dry powder aerosols of nanoparticulate drugs |
CZ303154B6 (cs) * | 1998-11-13 | 2012-05-09 | Jagotec Ag | Suchá prášková formulace k inhalaci obsahující stearát horecnatý |
NZ511689A (en) | 1998-11-18 | 2003-03-28 | Univ Florida | Methods for preparing coated drug particles useful for treating respiratory disorders or pulmonary infections |
US6984404B1 (en) | 1998-11-18 | 2006-01-10 | University Of Florida Research Foundation, Inc. | Methods for preparing coated drug particles and pharmaceutical formulations thereof |
GB9826783D0 (en) | 1998-12-04 | 1999-01-27 | Scherer Ltd R P | Inhalation powders |
GB9827145D0 (en) | 1998-12-09 | 1999-02-03 | Co Ordinated Drug Dev | Improvements in or relating to powders |
US6542490B1 (en) | 1999-01-29 | 2003-04-01 | Nortel Networks Limited | Data link control proctocol for 3G wireless system |
IT1309592B1 (it) | 1999-03-05 | 2002-01-24 | Chiesi Farma Spa | Particelle veicolo modificate da utilizzarsi nella preparazione diformulazioni farmaceutiche sotto forma di polimeri per inalazione e |
PL196951B1 (pl) | 1999-03-05 | 2008-02-29 | Chiesi Farma Spa | Proszek do stosowania w inhalatorze suchego proszku, cząsteczki nośnika i sposób wytwarzania nośnika |
WO2000061108A1 (en) * | 1999-04-14 | 2000-10-19 | Glaxo Group Limited | Pharmaceutical aerosol formulation |
US6406745B1 (en) | 1999-06-07 | 2002-06-18 | Nanosphere, Inc. | Methods for coating particles and particles produced thereby |
ITMI991582A1 (it) | 1999-07-16 | 2001-01-16 | Chiesi Farma Spa | Polveri costituite da particelle aventi la superficie perfettamente levigata da utilizzare come veicoli per la preparazione di miscele inala |
US6197369B1 (en) | 1999-09-30 | 2001-03-06 | New Jersey Institute Of Technology | Method of particle coating |
GB0008660D0 (en) | 2000-04-07 | 2000-05-31 | Arakis Ltd | The treatment of respiratory diseases |
PE20011227A1 (es) | 2000-04-17 | 2002-01-07 | Chiesi Farma Spa | Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros |
GB0009469D0 (en) | 2000-04-17 | 2000-06-07 | Vectura Ltd | Improvements in or relating to formalities for use in inhaler devices |
GB0009468D0 (en) | 2000-04-17 | 2000-06-07 | Vectura Ltd | Improvements in or relating to formulations for use in inhaler devices |
WO2002000197A1 (en) | 2000-06-27 | 2002-01-03 | Vectura Limited | Method of making particles for use in a pharmaceutical composition |
US6404772B1 (en) | 2000-07-27 | 2002-06-11 | Symbol Technologies, Inc. | Voice and data wireless communications network and method |
CA2425035A1 (en) | 2000-10-09 | 2002-04-18 | 3M Innovative Properties Company | Medicinal aerosol formulations |
BR0107304A (pt) | 2000-10-12 | 2002-08-13 | Boehringer Ingelheim Pharma | Pó para inalação contendo tiotrópio |
WO2002043700A2 (en) * | 2000-11-30 | 2002-06-06 | Vectura Limited | Particles for use in a pharmaceutical composition |
GB0124009D0 (en) | 2001-10-05 | 2001-11-28 | Vectura Ltd | Particles for use in a pharmaceutical composition |
EP2283818B1 (de) * | 2000-11-30 | 2017-08-02 | Vectura Limited | Herstellungsverfahren für Partikel zur Verwendung in einer Arrzneizusammensetzung |
US20060147389A1 (en) | 2004-04-14 | 2006-07-06 | Vectura Ltd. | Devices and pharmaceutical compositions for enhancing dosing efficiency |
WO2005025535A2 (en) | 2003-09-15 | 2005-03-24 | Vectura Limited | Methods for preparing pharmaceutical compositions |
GB0321607D0 (en) | 2003-09-15 | 2003-10-15 | Vectura Ltd | Manufacture of pharmaceutical compositions |
-
2001
- 2001-11-30 WO PCT/GB2001/005305 patent/WO2002043700A2/en not_active Application Discontinuation
- 2001-11-30 DE DE60140268T patent/DE60140268D1/de not_active Expired - Lifetime
- 2001-11-30 AU AU2002220857A patent/AU2002220857A1/en not_active Abandoned
- 2001-11-30 EP EP01998327.9A patent/EP1337239B2/de not_active Expired - Lifetime
- 2001-11-30 EP EP09173566.2A patent/EP2168571B1/de not_active Expired - Lifetime
- 2001-11-30 PT PT01998327T patent/PT1337239E/pt unknown
- 2001-11-30 US US10/433,135 patent/US8580306B2/en not_active Expired - Lifetime
- 2001-11-30 ES ES09173566.2T patent/ES2689704T3/es not_active Expired - Lifetime
- 2001-11-30 AT AT01998327T patent/ATE446085T1/de active
- 2001-11-30 EP EP10185079A patent/EP2292212A3/de not_active Withdrawn
- 2001-11-30 ES ES01998327.9T patent/ES2334642T5/es not_active Expired - Lifetime
-
2013
- 2013-10-10 US US14/050,819 patent/US9585839B2/en not_active Expired - Lifetime
-
2017
- 2017-02-15 US US15/433,106 patent/US10238601B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US8580306B2 (en) | 2013-11-12 |
US20040071635A1 (en) | 2004-04-15 |
EP1337239B1 (de) | 2009-10-21 |
EP1337239A2 (de) | 2003-08-27 |
PT1337239E (pt) | 2010-01-26 |
US9585839B2 (en) | 2017-03-07 |
ES2334642T3 (es) | 2010-03-15 |
DE60140268D1 (de) | 2009-12-03 |
AU2002220857A1 (en) | 2002-06-11 |
EP1337239B2 (de) | 2015-11-25 |
ES2689704T3 (es) | 2018-11-15 |
US20140037737A1 (en) | 2014-02-06 |
US10238601B2 (en) | 2019-03-26 |
WO2002043700A2 (en) | 2002-06-06 |
EP2168571A2 (de) | 2010-03-31 |
EP2168571B1 (de) | 2018-08-22 |
EP2168571A3 (de) | 2011-11-16 |
EP2292212A2 (de) | 2011-03-09 |
US20170216202A1 (en) | 2017-08-03 |
EP2292212A3 (de) | 2012-08-08 |
WO2002043700A3 (en) | 2002-10-24 |
ES2334642T5 (es) | 2016-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60140268D1 (de) | Partikel zur verwendung in einer pharmazeutischen zusammensetzung | |
WO2002039946A3 (en) | Packaging and delivery system for bone graft particles | |
LT2002010A (en) | Sulfur-containing fertilizer composition and method for preparing same | |
DE60217477D1 (de) | Kompositteilchen für dielektrika, ultrafeine harzkompositteilchen, zusammensetzung zur herstellung von dielektrika und verwendung derselben | |
DE69921941D1 (de) | Verfahren zur Herstellung von pharmazeutischen Wirkstoffpartikeln | |
NZ532312A (en) | Encapsulated materials | |
ATE264096T1 (de) | Verfahren und mittel zur verabreichung von insulin über die lunge | |
ATE382335T1 (de) | Verfahren zur vorbereitung von mikropartikeln zur verwendung in pharmazeutischen zusammensetzungen zur inhalation | |
DE60114002D1 (de) | VERFAHREN ZUR HERSTELLUNG KRISTALLINEr PARTIKEL ZUR INHALATION | |
DE60137039D1 (de) | Verschiebung von verschlüssen zur herstellung von windeln | |
AU2002316836A1 (en) | Dry mixture of embedding material or moulding material for metal casting, embedding or moulding material produced therefrom and the use of the same | |
IL161442A0 (en) | Keratinocytes which may be used as biologically active substances for the treatment of wounds | |
DE60203975D1 (de) | Verfahren zur Herstellung von magnetischen Teilchen, magnetische Teilchen und magnetischer Werkstoff | |
ATE389390T1 (de) | Neue formulierung zur inhalation mit einer bulkdichte zwischen 0,28 und 0,38 g/ml enthaltend budensonide | |
ATE257699T1 (de) | Neuartige formulierung zur inhalation mit einer bulkdichte zwischen 0.28 und 0.38 g/ml, mit formoterol | |
DE60227718D1 (de) | Verwendung von 2-Fuoro-3-Ketoestern zur Herstellung von 3-Fuoro-6,7,8,9-tetrahydro-4H-pyrimidoÄ1,2-aÜpyrimidin-4-onen | |
ATE380016T1 (de) | Aufstreuverfahren zur herstellung von pulverformulierungen | |
ATE293957T1 (de) | Verfahren zur herstellung von inhalationspulvern | |
DE50206912D1 (de) | Verfahren zur kontinuierlichen herstellung und beschichtung von selbstklebemassen auf basis von sbc mit mindestens einem pharmazeutischen wirkstoff | |
ATE459346T1 (de) | Stabile pulververabreichungsform zur inhalation | |
DE60212425D1 (de) | Fsh-zusammensetzungen mit hohem sialylierungsgrad und deren verwendung zur herstellung von arzneimitteln | |
DE60100500D1 (de) | Suspension enthaltend ein epi-hne protein, verfahren zu ihrer herstellung, daraus hergestelltes trockenpulveraerosol, arzneimittelzusammensetzungen enthaltend diese suspension oder dieses aerosol und ihre verwendungen | |
DE69823045D1 (de) | Neuartige formulierung zur inhalation mit einer bulkdichte zwischen 0.28 und 0.38 g/ml, mit terbutalinsulphat, verfahren zur herstellung der formulierung sowie anwendung derselben | |
WO2005041922A3 (en) | Composition | |
DE60239670D1 (de) | Verwendung von oxytocin zur herstellung einer pharmazeutischen zusammensetzung gegen karzinom in situ und zervizitis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1337239 Country of ref document: EP |